Home  |  Contact

UniProtKB/Swiss-Prot P56696: Variant p.Trp276Ser

Potassium voltage-gated channel subfamily KQT member 4
Gene: KCNQ4
Variant information

Variant position:  276
The position of the amino-acid change on the UniProtKB canonical protein sequence.

Type of variant:  Disease [Disclaimer]
The variants are classified into three categories: Disease, Polymorphism and Unclassified.
  • Disease: Variants implicated in disease according to literature reports.
  • Polymorphism: Variants not reported to be implicated in disease.
  • Unclassified: Variants with uncertain implication in disease according to literature reports. Evidence against or in favor of a pathogenic role is limited and/or conflicting.

Residue change:  From Tryptophan (W) to Serine (S) at position 276 (W276S, p.Trp276Ser).
Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.

Physico-chemical properties:  Change from large size and aromatic (W) to small size and polar (S)
The physico-chemical property of the reference and variant residues and the change implicated.

BLOSUM score:  -3
The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page

Variant description:  In DFNA2A.
Any additional useful information about the variant.

Other resources:  
Links to websites of interest for the variant.



Sequence information

Variant position:  276
The position of the amino-acid change on the UniProtKB canonical protein sequence.

Protein sequence length:  695
The length of the canonical sequence.

Location on the sequence:   VYLAEKDANSDFSSYADSLW  W GTITLTTIGYGDKTPHTWLG
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.

Residue conservation: 
The multiple alignment of the region surrounding the variant against various orthologous sequences.

Human                         VYLAEKDANSDFSSYADSLWWGTITLTTIGYGDKTPHTWLG

Mouse                         VYLAEKDANSDFSSYADSLWWGTITLTTIGYGDKTPHTWLG

Sequence annotation in neighborhood:  
The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.

TypePositionsDescription
Chain 1 – 695 Potassium voltage-gated channel subfamily KQT member 4
Intramembrane 271 – 292 Pore-forming; Name=Segment H5
Mutagenesis 261 – 261 K -> G. No effect on inhibition by potassium channel toxin SsTX.
Mutagenesis 262 – 262 D -> G. No effect on inhibition by potassium channel toxin SsTX.
Mutagenesis 266 – 266 D -> G. Resistant to inhibition by potassium channel toxin SsTX. Normal voltage activation.
Mutagenesis 268 – 268 S -> G. No effect on inhibition by potassium channel toxin SsTX.
Mutagenesis 272 – 272 D -> G. No effect on inhibition by potassium channel toxin SsTX.
Mutagenesis 288 – 288 D -> G. Resistant to inhibition by potassium channel toxin SsTX. Normal voltage activation.
Mutagenesis 290 – 290 T -> V. No effect on inhibition by potassium channel toxin SsTX.
Mutagenesis 292 – 292 H -> G. No effect on inhibition by potassium channel toxin SsTX.
Mutagenesis 295 – 295 L -> V. No effect on inhibition by potassium channel toxin SsTX.


Literature citations

Mutations in the KCNQ4 gene are responsible for autosomal dominant deafness in four DFNA2 families.
Coucke P.J.; Van Hauwe P.; Kelley P.M.; Kunst H.; Schatteman I.; Van Velzen D.; Meyers J.; Ensink R.J.; Verstreken M.; Declau F.; Marres H.; Kastury K.; Bhasin S.; McGuirt W.T.; Smith R.J.H.; Cremers C.W.R.J.; Van de Heyning P.; Willems P.J.; Smith S.D.; Van Camp G.;
Hum. Mol. Genet. 8:1321-1328(1999)
Cited for: VARIANTS DFNA2A SER-276; CYS-285 AND SER-321;

Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.